Shopping Cart 0
Cart Subtotal
USD 0

Europe Wound Care Biologics Market_Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 3200
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Europe wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for Europe wound care biologics market are listed below:

MiMedx

Organogenesis Inc.

Molnlycke Health Care AB

Integra Life Sciences

ConvaTec Inc.

BioHorizons IPH, Inc.

Anika Therapeutics, Inc.

Osiris Therapeutics, Inc.

Vericel Corporation

WRIGHT MEDICAL GROUP N.V.

The Europe wound care biologics market is segmented into:

Product Type

Wound Type

End User

On the basis of product type the Europe wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment isexpected to dominate the Europe wound care biologics market with highest market shares. However, allografts segment isexpected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.

On the basis of wound type the Europe wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Europe wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.

On the basis of end user Europe wound care biologics market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals segment is expected to dominate the Europe wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.

Based on geography, the market is segmented into:

Germany

France

U.K.

Spain

Italy

Switzerland

Netherlands

Russia

Turkey

Belgium

Rest of Europe

Covered in this report

The report covers the present scenario and the growth prospects of the Europe wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1 Introduction 30

1.1 Objectives Of The Study 30

1.2 Market Definition 30

1.3 Overview Of Europe Wound Care Biologics Market 30

1.4 Currency And Pricing 31

1.5 Limitation 31

1.6 Markets Covered 32

2 Market Segmentation 34

2.1 Markets Covered 34

2.2 Geographic Scope 35

2.3 Years Considered For The Study 36

2.4 Currency And Pricing 36

2.5 Research Methodology 37

2.6 Primary Interviews With Key Opinion Leaders 40

2.1 Dbmr Market Position Grid 41

2.2 Dbmr Market Challenge Matrix 42

2.3 Secondary Sources 43

2.4 Assumptions 43

3 Market Overview 44

3.1 Drivers 46

3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46

3.1.2 Increasing Incidences Of Burn Cases 46

3.1.3 Rising Number Of Geriatric Population 47

3.1.4 Innovation In Wound Care Biologics 48

3.1.5 New Product Launches 50

3.2 Restrains 50

3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50

3.2.2 Risk Of Skin Substitue Failure 51

3.3 Opportunities 52

3.3.1 3D Skin Printing 52

3.3.2 Awareness Programs 53

3.4 Challenges 54

3.4.1 Lack Of Wound Management Services 54

4 Executive Summary 55

5 Premium Insights 58

6 Europe Wound Care Biologics Market, By Product Type 63

6.1 Overview 64

6.2 Synthetic Skin Grafts 66

6.3 Growth Factors 67

6.3.1 Platelet Derived Growth Factor (Pdgf) 70

6.3.2 Platelet Rich Plasma (Prp) 70

6.3.3 Epidermal Growth Factors (Egf) 70

6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71

6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71

6.3.6 Talactoferrin Alfa 71

6.3.7 Thrombin Peptide 72

6.3.8 Keratinocy Growth Factor (Kgf) 72

6.4 Allografts 73

6.5 Xenografts 74

7 Europe Wound Care Biologics Market, By Wound Type 76

7.1 Overview 77

7.2 Wounds 78

7.2.1 Surgical Wound 80

7.2.1.1 Skin Surgery 81

7.2.1.1.1 Wound Closure 82

7.2.1.1.2 Skin Biopsy 82

7.2.1.1.3 Skin Flap 82

7.2.1.1.4 Skin Graft 82

7.2.1.1.5 Others 82

7.2.1.2 Cosmetic Procedure 83

7.2.1.2.1 Brest Enhancement 84

7.2.1.2.2 Facial Contouring 85

7.2.1.2.3 Facial Rejuvenation: 85

7.2.1.2.4 Body Contouring 85

7.2.1.2.5 Skin Rejuvenation 85

7.2.1.2.6 Others 86

7.2.1.3 Gynecologic Procedures 86

7.2.1.3.1 Pubovaginalis Sling 86

7.2.1.3.2 Pelvic Floor Reconstruction 87

7.2.1.3.3 Rectocele Repair Surgery 87

7.2.1.3.4 Others 87

7.2.1.4 Gastrointestinal Procedure 87

7.2.1.4.1 General Gastrointestinal Surgery 88

7.2.1.4.2 Hernia 89

7.2.1.4.3 Others 89

7.2.2 Acute Wounds 90

7.2.3 Chronic Wounds 90

7.2.4 Traumatic Wounds 91

7.3 Burns 91

7.3.1 Ulcers 92

7.3.2 Diabetic Ulcers 94

7.3.3 Pressure Ulcer 94

7.3.4 Venous Ulcer 95

7.3.5 Others 95

8 Europe Wound Care Biologics Market, By End User 96

8.1 Overview 97

8.2 Hospitals 99

8.3 Wound Care Centers 100

8.4 Ambulatory Surgical Centers 101

8.5 Clinics 103

8.6 Community Healthcare Center 104

9 Europe Wound Care Biologics Market: Geography 105

9.1 Europe 105

9.1.1 Germany 117

9.1.2 France 124

9.1.3 U.K. 131

9.1.4 Italy 138

9.1.5 Switzerland 145

9.1.6 Netherlands 152

9.1.7 Russia 160

9.1.8 Turkey 167

9.1.9 Spain 174

9.1.10 Belgium 181

9.1.11 Rest Of Europe 188

10 Europe Wound Care Biologics Market, Company Landscape 189

10.1 Company Share Analysis: Europe 189

11 Company Profile 190

11.1 Mimedx. 190

11.1.1 Company Overview 190

11.1.2 Revenue Analysis: 190

11.1.3 Company Share Analysis: 191

11.1.4 Product Portfolio 191

11.1.5 Recent Developments 192

11.2 Organogenesis Inc 193

11.2.1 Company Overview 193

11.2.2 Geographic Presence 193

11.2.3 Company Share Analysis: 194

11.2.4 Product Portfolio 194

11.2.5 Recent Developments 195

11.3 Integra Lifesciences 196

11.3.1 Company Overview 196

11.3.2 Revenue Analysis 196

11.3.3 Company Share Analysis: 197

11.3.4 Product Portfolio 197

11.3.5 Recent Developments 198

11.4 Convatec Inc. 199

11.4.1 Company Overview 199

11.4.2 Revenue Analysis 199

11.4.3 Company Share Analysis: 200

11.4.4 Product Portfolio : 200

11.4.5 Recent Developments 200

11.5 Acell Inc. 201

11.5.1 Company Overview 201

11.5.2 Product Portfolio 201

11.5.3 Recent Developments 202

11.6 Allosource 203

11.6.1 Company Overview 203

11.6.2 Product Portfolio 203

11.6.3 Recent Developments 204

11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 205

11.7.1 Company Overview 205

11.7.2 Product Portfolio 205

11.7.3 Recent Developments 205

11.8 Amnio Technology, Llc 206

11.8.1 Company Overview 206

11.8.2 Product Portfolio 206

11.8.3 Recent Developments 207

11.9 Amniox Medical, Inc. 208

11.9.1 Company Overview 208

11.9.2 Product Portfolio 208

11.9.3 Recent Developments 209

11.10 Anika Therapeutics, Inc. 210

11.10.1 Company Overview 210

11.10.2 Revenue Analysis 210

11.10.3 Product Portfolio 211

11.10.4 Recent Developments 211

11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 212

11.11.1 Company Overview 212

11.11.2 Geographicpresence 212

11.11.3 Product Portfolio 213

11.11.4 Recent Developments 213

11.12 Kerecis 214

11.12.1 Company Overview 214

11.12.2 Geographical Presence 214

11.12.3 Product Portfolio 215

11.12.4 Recent Developments 215

11.13 Marine Polymer Technologies, Inc 216

11.13.1 Company Overview 216

11.13.2 Product Portfolio 216

11.13.3 Recent Developments 216

11.14 Molnlycke Health Care Ab 217

11.14.1 Company Overview 217

11.14.2 Revenue Analysis 217

11.14.3 Product Portfolio 218

11.14.4 Recent Developments 218

11.15 Osiris Therapeutics, Inc. 219

11.15.1 Company Overview 219

11.15.2 Revenue Analysis 219

11.15.3 Product Portfolio 220

11.15.4 Recent Developments 220

11.16 Skye Biologics Inc. 221

11.16.1 Company Overview 221

11.16.2 Product Portfolio : 221

11.16.3 Recent Development: 222

11.17 Smith And Nephew 223

11.17.1 Company Overview 223

11.17.2 Revenue Analysis 223

11.17.3 Product Portfolio 224

11.17.4 Recent Developments 224

11.18 Solsys Medical. 225

11.18.1 Company Overview 225

11.18.2 Product Portfolio 226

11.18.3 Recent Developments 226

11.19 Vericel Corporation. 227

11.19.1 Company Overview 227

11.19.2 1.1.2 Revenue Analysis 227

11.19.3 Product Portfolio 228

11.19.4 Recent Developments 228

11.20 Wright Medical Group N.V 229

11.20.1 Company Overview 229

11.20.2 1.1.2 Revenue Analysis 229

11.20.3 Product Portfolio 230

11.20.4 Recent Developments 231

12 Related Reports 232


List Of Figure

List Of Figures

Figure 1 Europe Wound Care Biologics Market: Segmentation 23

Figure 2 Europe Wound Care Biologics Market: Data Triangulation 26

Figure 3 Europe Wound Care Biologics Market: Research Snapshot 27

Figure 4 Europe Wound Care Biologics Market: Bottom Up Approach 28

Figure 5 Europe Wound Care Biologics Market: Top Down Approach 28

Figure 6 Europe Wound Care Biologics Market: Interview Demographics 29

Figure 1 Europe Wound Care Biologics Market: Dbmr Market Position Grid 30

Figure 2 Europe Wound Care Biologics Market: The Market Challenge Matrix 31

Figure 3 Drivers, Restraints, Opportunities And Challenges Of Europe Wound Care Biologics Market 34

Figure 4 Aging Population In Different Countries (2014, 2017 & 2020) 37

Figure 5 Europe Wound Care Biologics Market: Segmentation 46

Figure 6 Increasing Prevelance Of Diabetic Foot Ulcers And Increasing Incidences Of Burn Cases Are Expected To Drive The Market For Europe Wound Care Biologics In The Forecast Period 2018 To 2025 47

Figure 7 Synthetic Skin Grafts In Europe Wound Care Biologics Is Expected To Account For The Largest Share Of The Europe Wound Care Biologics Market In 2018 & 2025 48

Figure 8 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Europe Wound Care Biologics Market In The Forecast Period From 2018 To 2025 49

Figure 9 Worldwide Prevalence Of Various Wound Types, 2011 50

Figure 10 Cases Of Burn Injuries, (2009-2012) 50

Figure 11 Prevalence Of Pressure Ulcers In Few Countries 51

Figure 12 Number Of Surgical Procedures And Surgical Site Infections 51

Figure 13 Europe Wound Care Biologics Market: By Product Type, 2017 53

Figure 14 Europe Wound Care Biologics Market: By Wound Type, 2017 66

Figure 15 Europe Wound Care Biologics Market: By End User, Snapshot 2017 86

Figure 16 Europe Wound Care Biologics Market: Snapshot (2017) 94

Figure 17 Europe Wound Care Biologics Market: By Country (2017) 95

Figure 18 Europe Wound Care Biologics Market: By Country (2018 & 2025) 96

Figure 19 Europe Wound Care Biologics Market, By Country (2017 & 2025) 97

Figure 20 Europe Wound Care Biologics Market, By Product Type (2018 -2025) 98

Figure 21 Europe Wound Care Biologics Market: Company Share 2017 (%) 178


List Of Table

List Of Tables

Table 1 Europe Wound Care Biologics Market, By Product Type, 2016- 2025 (Usd Million) 55

Table 2 Europe Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 56

Table 3 Europe Growth Factors In Wound Care Biologics Market, By Product Type, 2016- 2025 (Usd Million) 58

Table 4 Europe Growth Factors In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 59

Table 5 Europe Allografts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 63

Table 6 Europe Xenografts In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 65

Table 7 Europe Wound Care Biologics Market, By Wound Type, 2015- 2025 (Usd Million) 68

Table 8 Europe Wounds In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 69

Table 9 Europe Wounds In Wound Care Biologics Market, By Wound Type, 2016- 2025 (Usd Million) 69

Table 10 Europe Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million) 70

Table 11 Europe Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million) 71

Table 12 Number Of Cosmetic Surgery, 2016 & 2017 73

Table 13 Europe Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 74

Table 14 Europe Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 76

Table 15 Europe Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million) 78

Table 16 Europe Burns In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 82

Table 17 Europe Ulcers In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 83

Table 18 Europe Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million) 83

Table 19 Europe Wound Care Biologics Market, By End User, 2016-2025 (Usd Million) 88

Table 20 Europe Hospitals In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 89

Table 21 Europe Wound Care Center In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 90

Table 22 Statistics For Ambulatory Surgical Center. U.S. 91

Table 23 Europe Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 92

Table 24 Europe Clinics In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 93

Table 25 Europe Community Healthcare Center In Wound Care Biologics Market, By Region, 2016- 2025 (Usd Million) 94

Table 26 Europe Wound Care Biologics Market, By Country, Usd Million (2016-2025) 100

Table 27 Europe Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 101

Table 28 Europe Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 101

Table 29 Europe Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 102

Table 30 Europe Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 102

Table 31 Europe Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103

Table 32 Europe Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103

Table 33 Europe Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104

Table 34 Europe Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104

Table 35 Europe Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105

Table 36 Europe Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105

Table 37 Europe Wound Care Biologics, By End User, 2016-2025, (Usd Million) 106

Table 38 Germany Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 107

Table 39 Germany Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 108

Table 40 Germany Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 108

Table 41 Germany Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 109

Table 42 Germany Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 109

Table 43 Germany Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 110

Table 44 Germany Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 111

Table 45 Germany Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 111

Table 46 Germany Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112

Table 47 Germany Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112

Table 48 Germany Wound Care Biologics, By End User, 2016-2025, (Usd Million) 113

Table 49 France Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 114

Table 50 France Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 115

Table 51 France Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 115

Table 52 France Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 116

Table 53 France Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 116

Table 54 France Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 117

Table 55 France Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118

Table 56 France Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118

Table 57 France Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119

Table 58 France Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119

Table 59 France Wound Care Biologics, By End User, 2016-2025, (Usd Million) 120

Table 60 U.K. Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 121

Table 61 U.K. Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 122

Table 62 U.K. Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 122

Table 63 U.K. Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 123

Table 64 U.K. Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 123

Table 65 U.K. Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 124

Table 66 U.K. Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 125

Table 67 U.K. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 125

Table 68 U.K. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 126

Table 69 U.K. Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 126

Table 70 U.K. Wound Care Biologics, By End User, 2016-2025, (Usd Million) 127

Table 71 Italy Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 128

Table 72 Italy Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 129

Table 73 Italy Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 129

Table 74 Italy Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 130

Table 75 Italy Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 131

Table 76 Italy Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 131

Table 77 Italy Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 132

Table 78 Italy Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 132

Table 79 Italy Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 133

Table 80 Italy Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 133

Table 81 Italy Wound Care Biologics, By End User, 2016-2025, (Usd Million) 134

Table 82 Switzerland Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 135

Table 83 Switzerland Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 136

Table 84 Switzerland Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 136

Table 85 Switzerland Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 137

Table 86 Switzerland Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 137

Table 87 Switzerland Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 138

Table 88 Switzerland Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 139

Table 89 Switzerland Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 139

Table 90 Switzerland Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 140

Table 91 Switzerland Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 140

Table 92 Switzerland Wound Care Biologics, By End User, 2016-2025, (Usd Million) 141

Table 93 Netherlands Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 142

Table 94 Netherlands Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 143

Table 95 Netherlands Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 144

Table 96 Netherlands Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 144

Table 97 Netherlands Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 145

Table 98 Netherlands Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 145

Table 99 Netherlands Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 146

Table 100 Netherlands Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 147

Table 101 Netherlands Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 147

Table 102 Netherlands Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 148

Table 103 Switzerland Wound Care Biologics, By End User, 2016-2025, (Usd Million) 149

Table 104 Russia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 150

Table 105 Russia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 151

Table 106 Russia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 152

Table 107 Russia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 153

Table 108 Russia Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 153

Table 109 Russia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 154

Table 110 Russia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 154

Table 111 Russia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 155

Table 112 Russia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 155

Table 113 Russia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 156

Table 114 Russia Wound Care Biologics, By End User, 2016-2025, (Usd Million) 156

Table 115 Turkey Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 157

Table 116 Turkey Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 158

Table 117 Turkey Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 159

Table 118 Turkey Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 159

Table 119 Turkey Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 160

Table 120 Turkey Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 160

Table 121 Turkey Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 161

Table 122 Turkey Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 161

Table 123 Turkey Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 162

Table 124 Turkey Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 162

Table 125 Turkey Wound Care Biologics, By End User, 2016-2025, (Usd Million) 163

Table 126 Spain Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 164

Table 127 Spain Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 165

Table 128 Spain Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 165

Table 129 Spain Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 166

Table 130 Spain Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 166

Table 131 Spain Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 167

Table 132 Spain Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 168

Table 133 Spain Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 168

Table 134 Spain Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 169

Table 135 Spain Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 169

Table 136 Spain Wound Care Biologics, By End User, 2016-2025, (Usd Million) 170

Table 137 Belgium Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 171

Table 138 Belgium Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 172

Table 139 Belgium Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 172

Table 140 Belgium Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 173

Table 141 Belgium Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 173

Table 142 Belgium Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 174

Table 143 Belgium Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 175

Table 144 Belgium Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 175

Table 145 Belgium Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 176

Table 146 Belgium Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 176

Table 147 Belgium Wound Care Biologics, By End User, 2016-2025, (Usd Million) 177

Table 148 Rest Of Europe Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 178

?

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

MiMedx

Organogenesis Inc.

Integra LifeSciences

ConvaTec Inc.

Smith and Nephew

INTEGRA LIFE SCIENCES CORPORATION

Molnlycke Health Care AB